Granules India Ltd. (GRANULES): Granules India Share Price Rises 2.36% as Stock Ends Higher

Published: 17 September 2026 at 9:48:30 AM IST

Granules India Share Price moved higher today, with Granules India Ltd. closing at Rs 855.35, up 2.36% from the previous close of Rs 835.65. The stock added Rs 19.70 during the session, and the company’s market capitalisation stood at Rs 21,620.28 Cr. That makes the day’s move relevant for readers tracking Granules India Share Price Today, Granules India Stock News and broader stocks in news within the Indian stock market.

The session opened at Rs 842.00, traded between Rs 840.00 and Rs 855.90, and finished close to the day’s peak. The supplied data confirms a price rise in Granules India Share Price, but it does not establish a company-specific catalyst. For investors and market watchers, the most useful context today is the combination of the day move, the market cap, valuation ratios and the healthcare sector benchmark that frames Granules India Stock News today.

Granules India Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 855.35
Previous Close	Rs 835.65
Today's Move	Rs 19.7 (+2.36%)
Open	Rs 842
High	Rs 855.9
Low	Rs 840
Turnover	Rs 0.68 crore
Market Capitalisation	Rs 21,620.28 crore
Market Cap Category	Large Cap

Granules India Ltd. (GRANULES) rose to Rs 855.35 from the previous close of Rs 835.65, a move of Rs 19.7 or 2.36%. The stock opened at Rs 842, reached a high of Rs 855.9, recorded a low of Rs 840.

Granules India Share Price Today reflected a steady upward move across the session. The stock opened above the previous close, held near the upper end of the day’s range and finished at Rs 855.35 after rising Rs 19.70, or 2.36%. The intraday range of Rs 840.00 to Rs 855.90 shows that the share price rise was contained within a relatively narrow band, with the close sitting just below the day’s high. In short, the market data shows a clear gain in Granules India Share Price Today, while the verified figures do not identify a fresh company announcement behind the move.

Granules India Ltd. (GRANULES) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 21,620.28 crore
P/E Ratio	31.26x
P/B Ratio	4.23x
ROE	14.13%
ROCE	15.74%
EPS	Rs 26.73
Book Value Per Share	Rs 197.72
Dividend Yield	0.21%

Granules India Ltd. (GRANULES) fundamental metrics show P/E 31.26x, P/B 4.23x, ROE 14.13%, ROCE 15.74%. These figures provide context only and are not a buy or sell signal.

Granules India Ltd. has a market capitalisation of Rs 21620.28 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 31.26x, P/B at 4.23x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 14.13% and ROCE of 15.74%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 26.73, book value per share of Rs 197.72, dividend yield of 0.21%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 31.35x, median ROE of 11.78%, median ROCE of 13.65%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	31.26x
Benchmark Median P/E	31.35x
Benchmark Average P/E	47.81x
Benchmark P/E Range	3.45x to 661.74x
Company P/B Ratio	4.23x
Benchmark Median P/B	2.98x
Company ROE	14.13%
Benchmark Median ROE	11.78%
Company ROCE	15.74%
Benchmark Median ROCE	13.65%
Company Market Capitalisation	Rs 21,620.28 crore
Benchmark Median Market Cap	Rs 735.67 crore

Granules India Ltd. (GRANULES) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Granules India Ltd. (GRANULES) has a P/E ratio of 31.26x, which is below the benchmark median of 31.35x, a difference of -0.29%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Granules India Ltd. (GRANULES) has a ROE of 14.13%, which is above the benchmark median of 11.78%, a difference of +19.95%. Granules India Ltd. (GRANULES) has a ROCE of 15.74%, which is above the benchmark median of 13.65%, a difference of +15.31%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries Ltd.	SUNPHARMA	4,40,277.97	36.77	5.14	14.85	19.11
Divi's Laboratories Ltd.	DIVISLAB	2,43,965.63	83.5	13.83	16.19	21.51
Torrent Pharmaceuticals Ltd.	TORNTPHARM	1,84,478.41	84.11	20.44	26.76	19.27
Cipla Ltd.	CIPLA	1,09,949.53	32.59	3.12	11.83	16
Zydus Lifesciences Ltd.	ZYDUSLIFE	1,09,625.67	24.42	4.09	19.69	21.39

Granules India Ltd. (GRANULES) has a P/E ratio of 31.26x compared with the displayed peer median of 36.77x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 14.13% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 15.74% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Granules India Ltd. (GRANULES) has a market capitalisation of Rs 21,620.28 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Why Investors Are Watching Granules India

• Granules India Share Price rose 2.36% today to Rs 855.35.
• The stock added Rs 19.70 from the previous close of Rs 835.65.
• Market capitalisation stood at Rs 21,620.28 Cr at the close.
• P/E of 31.26 is close to the industry median of 31.35.
• ROE of 14.13% and ROCE of 15.74% are above the same-industry medians.

About Granules India

Granules India Ltd. is part of the Healthcare sector and the Pharmaceuticals & Drugs industry. The company’s share price movement is often followed by readers looking for Granules India Share Price Today, Granules India Latest News and Granules India Company News because it sits within a large listed pharmaceutical set and carries meaningful market capitalisation. Based on the supplied data, the business is assessed here through valuation, profitability and peer positioning rather than through any assumed event.

From a financial lens, Granules India Share Price is supported by an EPS of 26.73, a book value of Rs 197.72 and a dividend yield of 0.21%. Those figures help frame the company’s reported earnings power and per-share accounting base. For readers comparing healthcare names, the main point is that Granules India Stock Performance today must be read alongside its valuation, profitability and sector benchmark rather than in isolation.

Track Granules India Share Price on Univest

Use Granules India Ltd. (GRANULES) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Readers can track Granules India Share Price on Univest for live share price updates, fundamental ratios, market capitalisation, shareholding pattern, 52-week levels and broader market insights. Univest also helps users follow Granules India Share Price Live, Granules India Stock News and Granules India Share Price Update in one place.

Frequently Asked Questions

Why did Granules India Share Price rise today?

Ans. Granules India Share Price rose 2.36% to Rs 855.35, but the supplied data does not establish a company-specific catalyst. The verified session details only confirm the price rise, range and closing level.

What was Granules India Share Price Today?

Ans. Granules India Share Price Today closed at Rs 855.35, up Rs 19.70 from the previous close of Rs 835.65. The stock also traded between Rs 840.00 and Rs 855.90 during the session.

What is Granules India market capitalisation?

Ans. Granules India’s market capitalisation stood at Rs 21,620.28 Cr. That figure places the company well above the same-industry median and above the benchmark average, giving useful scale context for Granules India Share Price.

How is Granules India valued on P/E and P/B?

Ans. Granules India trades at a P/E of 31.26 and a P/B of 4.23. The P/E sits close to the industry median, while the P/B is slightly above the benchmark median and near the benchmark average.

What do Granules India EPS, book value and dividend yield show?

Ans. EPS is 26.73, book value is Rs 197.72 and dividend yield is 0.21%. EPS shows earnings attributable to each share, book value shows accounting net worth per share, and dividend yield shows historical payout.

How does Granules India compare with healthcare peers?

Ans. Granules India’s P/E of 31.26 is below Divi’s Laboratories and Torrent Pharmaceuticals but above Zydus Lifesciences. Its ROE and ROCE are above the industry medians, which gives the stock a balanced peer profile.

Which sector and industry does Granules India belong to?

Ans. Granules India belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. That placement matters because Granules India Share Price is often assessed against same-industry valuation, profitability and market-cap benchmarks.